Evidence map›Paper›PMID 35536483›Full record

ReviewNetherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation2022

Immediate versus staged revascularisation of non-culprit arteries in patients with acute coronary syndrome: a systematic review and meta-analysis.

P A Vriesendorp, J M Wilschut, R Diletti, J Daemen, I Kardys, F Zijlstra, N M Van Mieghem, J Bennett, G Esposito, M Sabate and 1 more

Abstract readReview
In one paragraph

Review in Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

P A VriesendorpDepartment of Cardiology, Thoraxcenter, Erasmus University Medical Centre, Rotterdam, The Netherlands.
J M WilschutDepartment of Cardiology, Thoraxcenter, Erasmus University Medical Centre, Rotterdam, The Netherlands.
R DilettiDepartment of Cardiology, Thoraxcenter, Erasmus University Medical Centre, Rotterdam, The Netherlands.
J DaemenDepartment of Cardiology, Thoraxcenter, Erasmus University Medical Centre, Rotterdam, The Netherlands.
I KardysDepartment of Cardiology, Thoraxcenter, Erasmus University Medical Centre, Rotterdam, The Netherlands.
F ZijlstraDepartment of Cardiology, Thoraxcenter, Erasmus University Medical Centre, Rotterdam, The Netherlands.
N M Van MieghemDepartment of Cardiology, Thoraxcenter, Erasmus University Medical Centre, Rotterdam, The Netherlands.
J BennettDepartment of Cardiovascular Medicine, University Hospitals Leuven, Leuven, Belgium.
G EspositoDivision of Cardiology, Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
M SabateCardiovascular Institute, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain.
W K den DekkerDepartment of Cardiology, Thoraxcenter, Erasmus University Medical Centre, Rotterdam, The Netherlands. w.dendekker@erasmusmc.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although there is robust evidence that revascularisation of non-culprit vessels should be pursued in patients presenting with an acute coronary syndrome (ACS) and multivessel coronary artery disease (MVD), the optimal timing of complete revascularisation remains disputed. In this systematic review and meta-analysis our results suggest that outcomes are comparable for immediate and staged complete revascularisation in patients with ACS and MVD. However, evidence from randomised controlled trials remains scarce and cautious interpretation of these results is recommended. More non-biased evidence is necessary to aid future decision making on the optimal timing of complete revascularisation.

Indexed as

Acute coronary syndromeMultivessel coronary artery diseasePercutaneous coronary intervention

Identifiers

PMID35536483
PMCPMC9474746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.